| Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group … AF Luetkemeyer, SL Rosenkranz, D Lu, F Marzan, P Ive, E Hogg, ... Clinical infectious diseases 57 (4), 586-593, 2013 | 77 | 2013 |
| Prediction of incident vertebral fracture using CT-based finite element analysis BT Allaire, D Lu, F Johannesdottir, D Kopperdahl, TM Keaveny, M Jarraya, ... Osteoporosis International 30, 323-331, 2019 | 74 | 2019 |
| Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248 A Andrade, SL Rosenkranz, AR Cillo, D Lu, ES Daar, JM Jacobson, ... The Journal of infectious diseases 208 (6), 884-891, 2013 | 67 | 2013 |
| Dynamics of immune reconstitution and activation markers in HIV+ treatment-naive patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabine NT Funderburg, A Andrade, ES Chan, SL Rosenkranz, D Lu, B Clagett, ... PloS one 8 (12), e83514, 2013 | 66 | 2013 |
| Perceived racism in relation to telomere length among African American women in the Black Women's Health Study D Lu, JR Palmer, L Rosenberg, AE Shields, EH Orr, I DeVivo, YC Cozier Annals of epidemiology 36, 33-39, 2019 | 52 | 2019 |
| Heritability and genetic correlations for bone microarchitecture: the Framingham Study families D Karasik, S Demissie, Y Zhou, D Lu, KE Broe, ML Bouxsein, LA Cupples, ... Journal of Bone and Mineral Research 32 (1), 106-114, 2017 | 39 | 2017 |
| Correspondence between bone mineral density and intervertebral disc degeneration across age and sex J Kaiser, B Allaire, PM Fein, D Lu, M Jarraya, A Guermazi, S Demissie, ... Archives of osteoporosis 13, 1-9, 2018 | 38 | 2018 |
| Combined Effect of CYP2B6 and NAT2 Genotype on Plasma Efavirenz Exposure During Rifampin-based Antituberculosis Therapy in the STRIDE Study AF Luetkemeyer, SL Rosenkranz, D Lu, B Grinsztejn, J Sanchez, ... Clinical Infectious Diseases 60 (12), 1860-1863, 2015 | 36 | 2015 |
| Early HIV RNA decay during raltegravir-containing regimens exhibits two distinct subphases (1a and 1b) A Andrade, J Guedj, SL Rosenkranz, D Lu, J Mellors, DR Kuritzkes, ... Aids 29 (18), 2419-2426, 2015 | 27 | 2015 |
| Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial R Gross, L Zheng, A La Rosa, X Sun, SL Rosenkranz, SW Cardoso, ... The lancet HIV 2 (1), e12-e19, 2015 | 19 | 2015 |
| Heterogeneity and spatial distribution of intravertebral trabecular bone mineral density in the lumbar spine is associated with prevalent vertebral fracture J Kaiser, B Allaire, PM Fein, D Lu, A Adams, DP Kiel, M Jarraya, ... Journal of Bone and Mineral Research 35 (4), 641-648, 2020 | 18 | 2020 |
| Virologic response, early HIV-1 decay, and maraviroc pharmacokinetics with the nucleos (t) ide-free regimen of maraviroc plus darunavir/ritonavir in a pilot study B Taiwo, EP Acosta, P Ryscavage, B Berzins, D Lu, J Lalezari, J Castro, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 64 (2), 167-173, 2013 | 18 | 2013 |
| Clustering of temporal gene expression data with mixtures of mixed effects models with a penalized likelihood D Lu, Y Tripodis, LC Gerstenfeld, S Demissie Bioinformatics 35 (5), 778-786, 2019 | 11 | 2019 |
| Bone strength estimated by micro‐finite element analysis (µFEA) is heritable and shares genetic predisposition with areal BMD: the Framingham Study D Karasik, S Demissie, D Lu, KE Broe, SK Boyd, CT Liu, YH Hsu, ... Journal of Bone and Mineral Research 32 (11), 2151-2156, 2017 | 10 | 2017 |
| Boceprevir and antiretroviral pharmacokinetic interactions in HIV/HCV co-infected persons: AIDS Clinical Trials Group study A5309s JJ Kiser, D Lu, SL Rosenkranz, GD Morse, R DiFrancesco, KE Sherman, ... Drugs in R&D 17, 557-567, 2017 | 6 | 2017 |
| Delayed reduction in CD4 T cell turnover following viral control correlates with markers of microbial trnaslocation in treatment-naive patients receiving RAL-based ART … N Funderburg, A Andrade, E Chan, D Lu, S Rosenkranz, J Jacobson Proceedings from the Conference on Retroviruses and Opportunistic Infections, 2011 | 6 | 2011 |
| Temporal and quantitative transcriptomic differences define sexual dimorphism in murine postnatal bone aging D Lu, S Demissie, NB Horowitz, AC Gower, ME Lenburg, YO Alekseyev, ... Journal of Bone and Mineral Research Plus 6 (2), e10579, 2022 | 5 | 2022 |
| Atazanavir pharmacokinetics and efficacy and safety outcomes by sex in AIDS Clinical Trials Group Study 5202 (A5202) C Venuto, K Mollan, Q Ma, E Daar, P Sax, M Fischl, A Collier, K Smith, ... 19th International AIDS Conference, Washington, DC, 22-27, 2012 | 4 | 2012 |
| Transcriptomic Assessment of Fracture Healing Under Hypophosphatemic Conditions Down Regulates Aerobic Oxidative Metabolism and Identifies Hippo and Canonical Wnt Regulation As … C Norton, D Lu, S Demissie, A Hussein, L Gerstenfeld JOURNAL OF BONE AND MINERAL RESEARCH 37, 286-286, 2022 | | 2022 |
| Temporal Transcriptomic Differences Define Sexual Dimorphism in Murine Post Natal Bone Homeostasis and Aging D Lu, S Demissie, N Horowitz, A Hussien, B Bragdon, D Daukss, J Page, ... JOURNAL OF BONE AND MINERAL RESEARCH 34, 327-327, 2019 | | 2019 |
